Related Experiment Video

Updated: Jul 18, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Classifying microRNAs in cancer: the good, the bad and the ugly

P Mathijs Voorhoeve1, Reuven Agami

  • 1Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. m.voorhoeve@nki.nl

Biochimica Et Biophysica Acta
|December 27, 2006
PubMed

Insights

MicroRNAs (miRNAs) are new gene regulators with roles in cancer. They are classified as "Good" (diagnostic), "Bad" (tumorigenic), or "Ugly" (destabilizing tumor identity), impacting cancer progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are emerging as critical gene regulators.
  • Altered miRNA expression is frequently observed in various cancers.
  • Understanding miRNA functions in cancer is an active area of research.

Purpose of the Study:

  • To classify the roles of miRNAs in cancer biology.
  • To explore the functional consequences of miRNA dysregulation in tumorigenesis.
  • To discuss experimental strategies for investigating miRNA mechanisms in cancer.

Main Methods:

  • Classification of miRNAs based on their involvement in cancer.
  • Review of existing literature on miRNA and cancer.
  • Discussion of potential experimental approaches.

Main Results:

  • Proposed classification of miRNAs into "Good", "Bad", and "Ugly" categories.
  • "Good" miRNAs: bystanders with diagnostic/prognostic potential.
  • "Bad" miRNAs: directly involved in oncogenesis.
  • "Ugly" miRNAs: destabilize tumor identity, promoting heterogeneity and progression.

Conclusions:

  • miRNAs play multifaceted roles in cancer, ranging from diagnostic markers to direct drivers of tumor development.
  • The "Good", "Bad", and "Ugly" classification provides a framework for understanding miRNA involvement in cancer.
  • Further research is needed to elucidate specific miRNA mechanisms and develop targeted therapies.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...